Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|July 3, 2002
The present and future of combination chemotherapy in bladder cancerStephane Culine
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in renal carcinomas]Damien Pouessel, Stephane Culine
Oncology Reports|December 6, 2005
Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancerPhilippe Mougenot, Michel Fabbro, Françoise Bressolle, et al.
The Journal of Urology|December 28, 2023
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER TrialYves Allory, Stephane Culine, Clémentine Krucker, et al.
Cancer|August 12, 2003
Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patientsDany Gholam, Karim Fizazi, Marie-Jose Terrier-Lacombe, et al.
Clinical Genitourinary Cancer|June 23, 2019
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysisThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.
Molecular and Clinical Oncology|August 6, 2020
Cervical bone pain revealing a bone metastatic colon cancer: A case reportYaqoub Alshatti, Shuaib Alqallaf, Wassim Allaham, et al.
American Journal of Nuclear Medicine and Molecular Imaging|March 23, 2026
Perspectives of positron emission tomography with 2-deoxy-2-fluorine-18-flu-d-glucose (18fdg-pet) in predicting the histological response of high grade epithelial ovarian cancer to neoadjuvant chemotherapy. A primary descriptive studyMichele Lamuraglia, Khadija Benali, Margot Bucau, et al.
Anticancer Research|August 21, 2003
Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary siteDamien Pouessel, Stephane Culine, Catherine Becht, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trialDavid Azria, Olivier Riou, Xavier Rebillard, et al.
Pageof 4